Atlas Trials

Study of NGM621 in Participants With Geographic Atrophy

Clinical trial NCT04014777 · COMPLETED

Trial details

NCT number
NCT04014777
Sponsor
NGM Biopharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Geographic Atrophy
Start date
2019-07-26
Primary completion
2020-05-27
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.